Ploegstra Wieteke M, Boontje Ronald P, Kamps Arvid W A
Department of Pediatrics, Medical Centre Leeuwarden, The Netherlands.
J Pediatr Pharmacol Ther. 2011 Apr;16(2):98-101. doi: 10.5863/1551-6776-16.2.98.
A 15-year-old white girl with autoimmune thyroiditis developed arthritis 3 weeks after starting therapy with the antithyroid drug thiamazole. Because an adverse drug reaction of thionamide therapy was suspected, thiamazole was withdrawn, and symptoms disappeared rapidly. Thionamide therapy is indicated for hyperthyroidism and has been widely used since 1948. Reported adverse drug reactions range from mild to potentially life threatening. Arthritis is an uncommon but serious side effect and can develop as a part of the antithyroid arthritis syndrome or as a part of antineutrophil cytoplasmic antibody-associated vasculitis that is induced by antithyroid drugs. Little is known about the exact pathogenesis. Therapy consists of prompt discontinuation of the drug, where upon symptoms rapidly disappear. Because of possible cross-reactivity with alternative thionamides, another form of treatment for hyperthyroidism is recommended. Clinical awareness is important, and prompt withdrawal of the antithyroid drug is necessary when serious side effects occur.
一名15岁患自身免疫性甲状腺炎的白人女孩在开始使用抗甲状腺药物甲巯咪唑治疗3周后出现关节炎。由于怀疑是硫酰胺类药物治疗的药物不良反应,停用了甲巯咪唑,症状迅速消失。硫酰胺类疗法适用于甲状腺功能亢进症,自1948年以来已被广泛使用。报告的药物不良反应从轻度到潜在的危及生命不等。关节炎是一种罕见但严重的副作用,可作为抗甲状腺关节炎综合征的一部分出现,或作为抗甲状腺药物诱发的抗中性粒细胞胞浆抗体相关血管炎的一部分出现。关于确切的发病机制知之甚少。治疗包括立即停药,症状会迅速消失。由于可能与其他硫酰胺类药物有交叉反应,建议采用另一种治疗甲状腺功能亢进症的方法。临床认识很重要,当出现严重副作用时,必须立即停用抗甲状腺药物。